11th Chemistry and Biology of Peptides Meeting – November 9, 2016
New Biochemistry Building, University of Oxford
A one day mini-symposium organized under the auspices of the British Peptide Society and the European Peptide Society
| November 9, 2016 | 11th Chemistry and Biology of Peptides Meeting Location: New Biochemistry Building, University of Oxford Oxford OX1 3QU Campus Map |
Register Now |
Agenda
| 10:00 | Registration and coffee |
| 10:25 | Introduction and Welcome from Organiser: Mark Howarth (University of Oxford) |
| 10:30 | Toward Precision Medicines for Metabolic Diseases Matthias Tschöp (Technical University of Munich) |
| 11:00 | Chemical synthesis and folding of mirror-image enzymes and chaperones Michael Jacobsen (University of Utah) |
| 11:30 | Coffee Break with Tea, coffee & biscuits |
| 12:00 | Identifying peptides from cancer to target immune killing Emma Hickman (Immunocore) |
| 12:30 | Peptide ligation technologies - a whiff of sulfur John Offer (Crick Institute) |
| 13:00 | Lunch Break and Poster presentations |
| 14:30 | Affimer technology Paul Ko Ferrigno (Avacta Life Sciences and University of Leeds) |
| 15:00 | Peptides & protons: mechanisms of proton coupled peptide transporters Joanne Parker (University of Oxford) |
| 15:30 | Coffee Break with Tea, coffee & biscuits |
| 16:00 | Announcement of Poster prizes |
| 16:05 | Chemical Ubiquitination Huib Ovaa (Netherlands Cancer Institute) |
| 16:35 | Novel approaches in Fmoc solid-phase peptide synthesis Peter White (Novabiochem, Merck KGaA, Darmstadt, Germany) |
| 16:50 | Meeting closed |
Confirmed Speakers
- Matthias Tschöp, Technical University of Munich
- Michael Jacobsen, University of Utah
- Emma Hickman, Immunocore
- John Offer, Francis Crick Institute
- Paul Ko Ferrigno, Avacta Life Sciences and University of Leeds
- Joanne Parker, University of Oxford
- Huib Ovaa, Netherlands Cancer Institute
- Peter White, Novabiochem, Merck KGaA, Darmstadt, Germany
Organisers
- Dr. Mark Howarth (University of Oxford)
- Dr. John Offer (Francis Crick Institute, Mill Hill)
- Dr. Peter White (Novabiochem, Merck KGaA, Darmstadt, Germany)